Frank Vinluan is a Senior Biopharma Reporter at MedCity News with over a decade of experience in business journalism. He specializes in explaining complex biotechnology topics to both expert and general audiences. Frank has covered a wide range of subjects, including Alzheimer's research, rare disease treatments, cancer immunotherapy, and venture capital investments in biotech. His expertise lies at the intersection of business and life sciences, making scientific discoveries accessible to investors and patients. Prior to MedCity News, he held positions at Xconomy, Triangle Business Journal, and freelanced for various industry publications.